Clinical MedicinePub Date : 2025-06-16DOI: 10.1016/j.clinme.2025.100333
Paramjit Uppal, Edward Coats, Charlotte Frise
{"title":"Fertility Treatments in Patients with Medical Conditions.","authors":"Paramjit Uppal, Edward Coats, Charlotte Frise","doi":"10.1016/j.clinme.2025.100333","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100333","url":null,"abstract":"<p><p>The use of assisted reproductive technology (ART) has dramatically changed the landscape for treatment of infertility. Increasingly healthcare practitioners of all specialisms are likely to encounter patients who have had ART, and therefore are expected to have knowledge of this area and counsel patients appropriately. There is, however, a lack of education about fertility techniques both at undergraduate and postgraduate level. Here we outline the main treatment options available to those undergoing ART, and the key considerations relevant to specialty physicians.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100333"},"PeriodicalIF":3.6,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-06-14DOI: 10.1016/j.clinme.2025.100338
Dr Caroline Barry, Dr Robert Brodrick, Dr Gurpreet Gupta, Dr Imranali Panjwani
{"title":"Palliative Sedation at the End of Life: Practical and Ethical Considerations.","authors":"Dr Caroline Barry, Dr Robert Brodrick, Dr Gurpreet Gupta, Dr Imranali Panjwani","doi":"10.1016/j.clinme.2025.100338","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100338","url":null,"abstract":"<p><p>Sedation is commonly used at the end of life, however there are several practical and ethical considerations for its use. It is important to identify any treatable causes for agitation prior to initiating medication. The drug, dose and route of administration may vary according to the indication for treatment, and specialist advice or supervision may be required. There are a number of ethical and cultural considerations relevant to the use of palliative sedation which must also be understood to ensure best practice in this area.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100338"},"PeriodicalIF":3.6,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144309659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-06-12DOI: 10.1016/j.clinme.2025.100340
Aleksandra Duffy, Susan Parker, Simon Williams, Kenneth Hodson, Simon Doe, Carlos Echevarria, Stephen J Bourke
{"title":"A descriptive cohort study of pregnancy and parenthood in women with cystic fibrosis.","authors":"Aleksandra Duffy, Susan Parker, Simon Williams, Kenneth Hodson, Simon Doe, Carlos Echevarria, Stephen J Bourke","doi":"10.1016/j.clinme.2025.100340","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100340","url":null,"abstract":"<p><p>Women with cystic fibrosis (wwCF) are increasingly undertaking pregnancy. This study assessed the current state of relationships, fertility, pregnancy and parenthood in a total cohort of 217 wwCF. Overall, 64% of wwCF were in long-term heterosexual relationships, 32% were single and 4% were in same-sex relationships; 64 wwCF had 111 children; 97 (87.4%) were conceived naturally and 10 (9%) by assisted reproduction. One woman had two children by surrogacy, one couple adopted a child and 6 had a role as a step-parent. Of the 217 wwCF 31 (14%) died at a mean age of 41.4 years; they had 18 children and 8 (44%) were less than 18 years old when the mother died. There was a marked increase in pregnancies associated with the introduction of CF modulator medications, from 3 in 2020 to 16 in 2023. There were 50 pregnancies between 2020 and 2024;17 (34%) were not planned (5 were terminated); and 15 (30%) partners did not have CF genetic tests pre-conception. There were 8 miscarriages. Exacerbations of lung disease occurred in 11 (31%) completed pregnancies, gestational diabetes in 12 (34%), one gastrointestinal bleeding, and one pre-eclampsia. Delivery was by caesarean section in 14 (40%) and 4 (11%) births were pre-mature (<37 weeks gestation). Although outcomes are generally good, pre-conception planning is suboptimal, pregnancy is associated with increased complications and parenthood raises complex issues regarding prognosis. CF teams should have close links with maternal medicine services to meet the specific needs of wwCF.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100340"},"PeriodicalIF":3.6,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144293419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-06-08DOI: 10.1016/j.clinme.2025.100337
Jonathan Ayling-Smith, Richard Attanoos, Nicola-Xan Hutchinson
{"title":"Some sage advice: a case report of sage burning causing interstitial lung disease.","authors":"Jonathan Ayling-Smith, Richard Attanoos, Nicola-Xan Hutchinson","doi":"10.1016/j.clinme.2025.100337","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100337","url":null,"abstract":"<p><strong>Background: </strong>Cigarette smoking remains the commonest cause of chronic obstructive pulmonary disease (COPD) and respiratory bronchiolitis-associated interstitial lung disease (RB-ILD). Biomass combustion remains a high risk for causing respiratory disease.</p><p><strong>Method: </strong>We present a case of a 41-year-old woman and never-smoker with worsening breathlessness. It was identified that she made fire pits burning sage and oils for spiritual work but beyond this had no respiratory risk factors.</p><p><strong>Results: </strong>Radiological evidence of RB-ILD was identified and a bronchoscopic lavage demonstrated the presence of striking green pigmented macrophages, presumed to be chlorophyll uptake.</p><p><strong>Conclusions: </strong>Cessation of burning sage exposure has resulted in a positive outcome. This case highlights the need for an extensive occupational or exposure history in respiratory medicine and describes histological features of interstitial lung disease not previously identified.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100337"},"PeriodicalIF":3.6,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144265518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparisons of efficacy and safety of immunotherapies for Alzheimer's disease treatment: a network meta-analysis of randomized controlled trials.","authors":"Ching-Hui Su, Ying-Tzu Chang, Huan-Shu Tseng, Chan-Yen Kuo, Jin-Hua Chen, Po- Yu Chien, Yao-Jen Chang, Chin-Chuan Hung","doi":"10.1016/j.clinme.2025.100336","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100336","url":null,"abstract":"<p><strong>Background: </strong>Alzheimer's disease (AD) remains a major challenge due to limited effective therapies. Moreover, direct comparisons between newly developed and symptomatic drugs are lacking. This network meta-analysis aimed to compare the efficacy and safety of immunotherapies for AD.</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov was conducted for randomised controlled trials (RCTs) up to 29 June 2024. Eligible studies included adults with AD receiving immunotherapy versus placebo or symptomatic treatment.</p><p><strong>Results: </strong>Fifty-nine RCTs were included. Donanemab and lecanemab ranked among the most effective treatments for improving cognitive function (Clinical Dementia Rating Scale-Sum of Boxes P-scores: 0.88 and 0.77) and daily activities (Alzheimer's Disease Cooperative Study-Activities of Daily Living P-scores: 0.85 and 0.90), based on network meta-analysis findings.</p><p><strong>Conclusions: </strong>Anti-Aβ mAbs, particularly donanemab and lecanemab, demonstrated superior efficacy over other immunotherapies in slowing cognitive deterioration, supporting their role in AD management.</p><p><strong>Prospero registration number: </strong>CRD42023461680.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100336"},"PeriodicalIF":3.6,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-06-03DOI: 10.1016/j.clinme.2025.100334
Avan Aihie Sayer
{"title":"Harveian Oration 2024: From bench to bedside and beyond - new horizons for translational ageing research.","authors":"Avan Aihie Sayer","doi":"10.1016/j.clinme.2025.100334","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100334","url":null,"abstract":"","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100334"},"PeriodicalIF":3.6,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-05-27DOI: 10.1016/j.clinme.2025.100330
A Barnes, G Heppenstall-Harris, A Dickman
{"title":"Opioid analgesics: Managing the predictable.","authors":"A Barnes, G Heppenstall-Harris, A Dickman","doi":"10.1016/j.clinme.2025.100330","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100330","url":null,"abstract":"","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100330"},"PeriodicalIF":3.6,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-05-26DOI: 10.1016/j.clinme.2025.100332
Ping-Jui Tsai, Yu-Jen Kuo
{"title":"Impact of chronic liver disease (CLD) on mortality, complications, and early readmission in patients with spontaneous intracranial hemorrhage (ICH): A National Readmission Database Analysis 2016-2020.","authors":"Ping-Jui Tsai, Yu-Jen Kuo","doi":"10.1016/j.clinme.2025.100332","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100332","url":null,"abstract":"<p><strong>Background: </strong>Chronic liver disease (CLD) is associated with worse outcomes in many medical conditions, but its impact on patients with spontaneous intracranial hemorrhage (ICH) has not been fully explored. This study aims to evaluate the influence of CLD on in-hospital outcomes of patients with a spontaneous ICH.</p><p><strong>Methods: </strong>Data from the Nationwide Readmissions Database (NRD) between 2016 and 2020 were retrospectively reviewed. Patients ≥ 18 years old admitted for the first time with a spontaneous ICH were included. Study outcomes included in-hospital mortality, length of stay (LOS), major complications, and 90-day readmission rate. Patients with and without CLD were matched using 1:4 propensity score matching (PSM). Univariate and multivariable logistic and linear regression analyses were performed to determine the associations between CLD and outcomes of interest.</p><p><strong>Results: </strong>After applying PSM, 21,345 patients were included in the analysis of which 4,269 had CLD. After adjustment, compared to patients without CLD, those with CLD had significantly higher in-hospital mortality (adjusted odds ratio [aOR] = 1.23, 95% confidence interval [CI]: 1.13-1.34, p < 0.001), a longer LOS(aOR = 1.26, 95% CI: 1.12-1.39, p < 0.001), higher rates of major complications(aOR = 1.76, 95% CI: 1.62-1.91, p < 0.001), and increased 90-day readmission rates (aOR = 1.20, 95% CI: 1.09-1.31, p < 0.001).</p><p><strong>Conclusions: </strong>CLD is independently associated with higher mortality, more complications, longer LOS, and higher readmission rates in patients admitted for spontaneous ICH. These findings underscore the need for specialized care strategies for patients with an ICH and underlying CLD.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100332"},"PeriodicalIF":3.6,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-05-26DOI: 10.1016/j.clinme.2025.100331
Abhishek Abhishek, Edoardo Cipolletta
{"title":"Gout on the acute medical take.","authors":"Abhishek Abhishek, Edoardo Cipolletta","doi":"10.1016/j.clinme.2025.100331","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100331","url":null,"abstract":"<p><p>Gout is the commonest form of inflammatory arthritis. Flares are the commonest presentation of gout. Typically, gout flares present as acute mono-arthritis, and most often affect the first metatarsophalangeal joint (\"podagra\"). Other joints in the lower limbs are affected more often than those in the upper limbs. Joint aspiration followed by examination of the synovial fluid using a polarized light microscope is the gold standard for a definite diagnosis of gout. Gout may be diagnosed without recourse to joint aspiration if there is podagra, elevated serum urate, and no suspicion of infection. Ultrasonography and dual energy computed tomography may be used to diagnose gout if joint aspiration is unsuccessful or not feasible. Oral colchicine, NSAIDs, and glucocorticoids have similar efficacy for controlling gout flare with differing adverse effect profiles. Consequently, the drug choice depends on comorbidities and patient preference.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100331"},"PeriodicalIF":3.6,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-05-09DOI: 10.1016/j.clinme.2025.100325
Gerard Gurumurthy, Lianna Reynolds, Kerstin de Wit, Lara N Roberts, Jecko Thachil
{"title":"Is pulmonary embolism a chronic disease?","authors":"Gerard Gurumurthy, Lianna Reynolds, Kerstin de Wit, Lara N Roberts, Jecko Thachil","doi":"10.1016/j.clinme.2025.100325","DOIUrl":"10.1016/j.clinme.2025.100325","url":null,"abstract":"<p><p>Pulmonary embolism (PE) is often regarded as an acute disorder, yet emerging evidence underscores its chronic trajectory. Many survivors endure long-term complications, including recurrent thrombosis, persistent dyspnoea and psychosocial challenges. These sequelae impair functional capacity and quality of life long after the initial event. To address these issues, we suggest that clinicians should adopt an integrated, multidisciplinary model that includes risk stratification for recurrence, structured follow-up, exercise rehabilitation, and support for psychological challenges. Recognising the potential chronic sequalae of PE ultimately fosters comprehensive care aimed at reducing morbidity and improving long-term outcomes for survivors.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100325"},"PeriodicalIF":3.6,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143981907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}